Full
Outline
To evaluate the effect of a comprehensive intervention program for individuals at high risk of cardiovascular disease in the Inner Mongolia Autonomous Region, and to provide a reference for the prevention and control of cardiovascular diseases in this region.
Data from the Inner Mongolia Autonomous Region Cardiovascular Disease High-Risk Population Early Screening and Comprehensive Intervention Project (2015—2024) were used to identify 3 354 high-risk individuals. Based on inclusion and exclusion criteria, these participants received comprehensive interventions over a 10-year period. Changes in lipid profiles, blood glucose, and blood pressure levels before and after the intervention were analyzed to assess the effectiveness of the program.
After 10 years of comprehensive intervention, total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) levels decreased (t=23.477, t=18.013), while high-density lipoprotein cholesterol (HDL-C) and triglyceride (TG) levels increased (t=-4.096, t=-9.154). Fasting blood glucose levels also increased (t=-14.725). Systolic blood pressure (SBP) and diastolic blood pressure (DBP) decreased from 160.16±22.76 mmHg and 93.10±12.75 mmHg to 140.98±18.65 mmHg and 84.89±10.94 mmHg, respectively (t=49.481, t=38.451). All these changes were statistically significant (P<0.001). Analysis of intervention effects showed that the rates of dyslipidemia and abnormal blood pressure decreased (χ2=23.369, P<0.001; χ2=359.194, P<0.001), while the rate of abnormal blood glucose increased (χ2=357.752, P<0.001), with all differences being statistically significant.
The implementation of comprehensive interventions for populations at high risk of cardiovascular disease in the Inner Mongolia Autonomous Region is beneficial in reducing the prevalence of dyslipidemia and hypertension, highlighting its public health significance. However, close monitoring of triglyceride (TG) and fasting blood glucose levels is necessary, and further research is needed to explore their impact on cardiovascular disease.
26
13
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |
关闭全屏
No. 86 Xueyuan South Road, Haidian District, Beijing
010-62662699(Operation and Technical Support)
qkjq@cast.org.cn
Copyright © 2025 China Association for Science and Technology. All rights reserved. For all open access content, the relevant licensing terms apply.
Sponsored by the Office of the Leading Group for Cybersecurity and Informatization of CAST, and supported by Science and Technology Review Publishing House
